Siblings Books/Book Section [3/5] Periodical Articles [412/413] Collection Statistics Item counts issued in 3 years:6(11.32%) Items With Fulltext:49(92.45%) Download counts of the item Download times greater than 0:49(100.00%) Download times greater than 100:45(91.84%) Total Bitstream Download Counts:18826(13.66%) Last Update: 2024-11-28 10:47 Top Upload Loading... Top Download Loading... Recent Submissions MPO and trh within leukemia stem ce... Development of an artificial intell... Improving Interoperability in Healt... ILLUMINATE: Efficacy and safety of ... Association between dietary pattern... What can the anti-apoptotic molecul... Differences in gut microbiota profi... Pathogenic role of specific macroph... Nivolumab plus ipilimumab as neoadj... A phase I study of biweekly abraxan...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-50 of 53. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page

Date	Title	Relation
2024-01-30	Improving Interoperability in Healthcare: A User-Friendly International Standard Data Conversion Framework	Lecture Notes in Electrical Engineering. 2024 Jan 30;1133:326-335.
2024-01-30	Development of an artificial intelligence-based precise nutrition and dietary management model with nutrient intake recommendation framework	Lecture Notes in Electrical Engineering. 2024 Jan 30;1133:336-344.
2023-11-28	MPO and trh within leukemia stem cells increased chemosensitivity in acute myeloid leukemia: A single-cell RNA sequencing approach	Blood. 2023 Nov 28;142(Suppl. 1):Meeting Abstract 4323.
2023-11	ILLUMINATE: Efficacy and safety of durvalumab-tremelimumab and chemotherapy in EGFR mutant NSCLC following progression on EGFR inhibitors	Journal of Thoracic Oncology. 2023 Nov;18(11, Suppl.):S63.
2023-08-03	Association between dietary patterns, anthropometric status, lifestyle, and bone mineral density among postmenopausal women in Taiwan: A cross-sectional study	Annals of Nutrition and Metabolism. 2023 Aug 03;79(Suppl. 1):926.
2022-02	What can the anti-apoptotic molecule, BIRC5/Survivin, do in the autophagic world?	Cancer Science. 2022 Feb;113(S1):41.
2021-10	Pathogenic role of specific macrophage and fibroblast subpopulations in acne keloidalis identified by single cell RNA sequencing	Journal of Investigative Dermatology. 2021 Oct;141(10):S211.
2021-07	A phase I study of biweekly abraxane in combination with oxaliplatin and oral S-1/leucovorin as first line treatment for advanced gastric, pancreatic and biliary tract cancers	Annals of Oncology. 2021 Jul;32(Suppl. 3):S146-S147.
2021-07	Nivolumab plus ipilimumab as neoadjuvant therapy for potentially resectable hepatocellular carcinoma	Annals of Oncology. 2021 Jul;32(Suppl. 3):S141-S141.
2021-05	Differences in gut microbiota profiles and functions between end-stage kidney disease and healthy populations	Nephrology Dialysis Transplantation. 2021 May;36(Suppl.):I54-I55.
2019-05	Oral paclitaxel in the treatment of metastatic breast cancer (MBC) patients	Journal of Clinical Oncology. 2019 May;37(15, Suppl. S):Abstract number 1084.
2018-03-01	Vocal analysis of speech in adults with autism spectrum disorders	Acoustical Science and Technology. 2018 Mar 1;39(2):154-157.
2018-01	Epigenetic regulation of LDHA dictates the gemcitabine resistance in pancreatic cancer	Cancer Science. 2018 Jan;109(Suppl. 1):1146.
2016-02	JAK2 overexpression is a prognostic indicator for worse outcome in nasopharyngeal carcinoma and is independent of JAK2 exon 12 and JAK2 V617F mutation	Laboratory Investigation. 2016 Feb;96(Suppl. 1):325A.
2016-02	JAK2 overexpression is a prognostic indicator for worse outcome in nasopharyngeal carcinoma and is independent of JAK2 exon 12 and JAK2 V617F mutation	Modern Pathology. 2016 Feb;29(Suppl. 2):325A.
2014-12	Studying the molecular mechanism underlying dissemination of pancreatic ductal adenocarcinoma after surgical resection	Biomarkers and Genomic Medicine. 2014 Dec;6(4):196.
2014-10	Amacr gene amplification and protein overexpression in primary imatinib-naive gastrointestinal intestinal stromal tumors	Annals of Oncology. 2014 Oct;25:Article number P1-2-1.
2014-05	AMACR overexpression is associated with clinical and biological aggressiveness in urothelial carcinomas of the upper urinary tract and urinary bladder	European Journal of Cancer. 2014 May;50(Suppl. 4):e35.
2014-05	MMP11 overexpression: Poor prognosis in patients with urothelial carcinoma of the upper tract and urinary bladder	European Journal of Cancer. 2014 May;50(Suppl. 4):e43.
2014-05	PTP4A3 overexpression predicts clinical aggressiveness in urothelial carcinoma	European Journal of Cancer. 2014 May;50(Suppl. 4):e42-e43.
2014-05	Cyclin-dependent kinase 4 overexpression confers an independent prognosticator of nasopharyngeal carcinoma	European Journal of Cancer. 2014 May;50(Suppl. 4):e68.
2014-05	CSF2 overexpression as a poor prognostic factor in patients with urothelial carcinoma of the upper urinary tract and urinary bladder	European Journal of Cancer. 2014 May;50(Suppl. 4):e35-e36.
2014-05	Overexpression of DPP4 is a poor prognostic factor for patients with urothelial carcinoma of the upper urinary tract and urinary bladder	European Journal of Cancer. 2014 May;50(Suppl. 4):e39.
2014-02	CDCA5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tract and urinary bladder	Modern Pathology. 2014 Feb;27(Suppl. 2):220A.
2014-02	HOXC6 overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma	Modern Pathology. 2014 Feb;27(Suppl. 2):331A.
2014-02	SLC14A1 down-regulation is associated with poor clinical outcome in patients with urothelial carcinoma of upper urinary tracts and urinary bladder	Modern Pathology. 2014 Feb;27(Suppl. 2):245A.
2014-02	Characterization of the clinical, biological, and therapeutic relevance of EZH2 overexpression in myxofibrosarcoma	Modern Pathology. 2014 Feb;27(Suppl. 2):22A.
2014-02	CDCA5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tract and urinary bladder	Laboratory Investigation. 2014 Feb;94(S1):220A.
2014-02	SLC14A1 down-regulation is associated with poor clinical outcome in patients with urothelial carcinoma of upper urinary tracts and urinary bladder	Laboratory Investigation. 2014 Feb;94(S1):245A.
2014-02	HOXC6 overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma	Laboratory Investigation. 2014 Feb;94(S1):331A.
2014-02	Characterization of the clinical, biological, and therapeutic relevance of EZH2 overexpression in myxofibrosarcoma	Laboratory Investigation. 2014 Feb;94(S1):22A.
2013-10	STMN1 overexpression as a poor prognostic factor in patients with Nasopharyngeal Carcinoma	International Journal of Radiation Oncology Biology Physics. 2013 Oct;87(2, Supple. 1):S666-S667.
2013-02	GFBP5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder	Modern Pathology. 2013 Feb;26(Suppl. 2):230A.
2013-02	Periostin overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma	Modern Pathology. 2013 Feb;26(Suppl. 2):308A.
2013-02	TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma	Modern Pathology. 2013 Feb;26(Suppl. 2):308A.
2013-02	Angiomatoid fibrous histiocytoma: Clincopathological and molecular characterization with emphasis on variant histomorphology	Laboratory Investigation. 2013 Feb;93(Suppl. 1):14A.
2013-02	TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma	Laboratory Investigation. 2013 Feb;93(Suppl. 1):308A.
2013-02	GFBP5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder	Laboratory Investigation. 2013 Feb;93(Suppl. 1):230A.
2013-02	Angiomatoid fibrous histiocytoma: Clincopathological and molecular characterization with emphasis on variant histomorphology	Modern Pathology. 2013 Feb;26(Suppl. 2):14A.
2013-02	Periostin overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma	Laboratory Investigation. 2013 Feb;93(Suppl. 1):308A.
2011-05	Size effect on tumor treatment with PEGylated liposomal drugs in a tumor-bearing mouse model	Journal of Nuclear Medicine. 2011 May;52(Suppl. 1):Meeting Abstract 1737.
2011-04	Early Treg suppression by a Listeriolysin-O-expressing E. coli vaccine in heterologous prime-boost vaccination against cancer	Journal of Immunology. 2011 Apr;186(Suppl. 1):Meeting Abstract 165.49.
2011-04	SOX1 functions as a tumor suppressor through antagonizing WNT/beta-catenin signaling pathway in hepatocellular carcinoma	Cancer Research. 2011 Apr;71(Suppl. 8):Meeting Abstract 2199.
2009-11	Characterization of three tyrosine kinase-related gene mutations at the EGFR exons 19-21 and amplification of the EGFR gene in colorectal cancer patients	Journal of Molecular Diagnostics. 2009 Nov;11(6):654-655.
2009-07	Down-regulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome	Oral Oncology Supplement. 2009 Jul;3(1):73.
2009-05	Cellular and functional heterogeneity of the sarcomatoid renal cell carcinoma cell line RCC52 with total loss of HLA class I: A system to study mesenchymalepithelial transition	Cancer Research. 2009 May;69:Abstract number 222.
2009-05	Characterization of naturally occurring floating cells and adherent cells within the CEA-producing UP-LN1 carcinoma cell line in vitro: Identification of cancer stem cells with metastatic potential	Cancer Research. 2009 May;69:Abstract number 188.
2009-05	The basal body gene, RPGRIP1L, is a candidate tumor suppressor gene on chromosome 16q12.2 in human hepatocellular carcinoma	Cancer Research. 2009 May;69(9):Meeting Abstract 4950.
2009-05	Evaluation therapeutic efficacy of In111-VNB-liposome with dual reporter gene in human colorectal carcinoma HT-29 xenografts	Journal of Nuclear Medicine. 2009 May;50(Suppl. 2):Meeting Abstract 2306.
2009-05	Molecular imaging-based passive targeted therapeutic efficacy with pegylated liposome encapsulated with 111In and vinorelbine in colon carcinoma xenografts	Journal of Nuclear Medicine. 2009 May;50(Suppl. 2):Meeting Abstract 2303.

Showing items 1-50 of 53. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page